Overview of Middlefield Canadian Income PCC
Middlefield Canadian Income PCC is a well-respected investment entity organized as a protected cell company and registered in Jersey. In this article, we will explore the net asset value (NAV) and provide insights into its investment strategies.
Analysis of Current Net Asset Value
As of the most recent date available, the estimated unaudited net asset value per share is 127.54 pence. This amount includes accrued income and reflects the company’s financial position at the end of the trading day.
Methodology for Investment Valuation
Middlefield Canadian Income PCC uses a bid price basis to value its investment portfolio. This approach offers a realistic evaluation of the company's assets, promoting both transparency and accuracy.
Operational Structure of the Company
As a well-established entity, Middlefield Canadian Income PCC has a diverse range of investments that enhance its NAV. Its structure as a protected cell company facilitates effective management of its unique investment mandates.
Contacting Us for Inquiries
If you have any questions about investments or operational aspects, please feel free to contact JTC Fund Solutions (Jersey) Limited at 01534 700 000.
Frequently Asked Questions
What is the current NAV for Middlefield Canadian Income PCC?
The latest estimated unaudited NAV is 127.54 pence per share, which includes accrued income.
How does Middlefield Canadian Income PCC value its assets?
The company employs a bid price basis for valuing its investment portfolio, ensuring a transparent assessment of its assets.
What is the structure of Middlefield Canadian Income PCC?
It operates as a protected cell company registered in Jersey, which enhances its investment efficiency.
Who can I contact for inquiries about Middlefield Canadian Income PCC?
For any inquiries, you can reach out to JTC Fund Solutions (Jersey) Limited at 01534 700 000.
What advantages does a protected cell company structure offer?
This structure enables the independent management of various investments while safeguarding individual cell assets from the liabilities of others.
